Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine.

Mesholam-Gately RI, Gibson LE, Seidman LJ, Green AI.

Schizophr Res. 2014 May;155(1-3):45-51. doi: 10.1016/j.schres.2014.03.002. Epub 2014 Mar 29.

PMID:
24685823
[PubMed - in process]
2.

Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms.

Bernacer J, Corlett PR, Ramachandra P, McFarlane B, Turner DC, Clark L, Robbins TW, Fletcher PC, Murray GK.

Am J Psychiatry. 2013 Nov 1;170(11):1326-34. doi: 10.1176/appi.ajp.2013.12070978.

PMID:
23732871
[PubMed - indexed for MEDLINE]
3.

A brief history of oxytocin and its role in modulating psychostimulant effects.

Carson DS, Guastella AJ, Taylor ER, McGregor IS.

J Psychopharmacol. 2013 Mar;27(3):231-47. doi: 10.1177/0269881112473788. Epub 2013 Jan 23. Review.

PMID:
23348754
[PubMed - indexed for MEDLINE]
4.

Cigarette smoking modulates medication-associated deficits in a monetary reward task in patients with schizophrenia.

Lernbass B, Grön G, Wolf ND, Abler B.

Eur Arch Psychiatry Clin Neurosci. 2013 Sep;263(6):509-17. doi: 10.1007/s00406-012-0370-3. Epub 2012 Sep 26.

PMID:
23010839
[PubMed - indexed for MEDLINE]
5.

Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity.

Zhao C, Li M.

Pharmacol Biochem Behav. 2012 Dec;103(2):174-80. doi: 10.1016/j.pbb.2012.08.021. Epub 2012 Aug 31.

PMID:
22960130
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.

Bédard AM, Maheux J, Lévesque D, Samaha AN.

Schizophr Bull. 2013 May;39(3):692-702. doi: 10.1093/schbul/sbs077. Epub 2012 Aug 27.

PMID:
22927669
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Neurobiological correlates of delusion: beyond the salience attribution hypothesis.

Pankow A, Knobel A, Voss M, Heinz A.

Neuropsychobiology. 2012;66(1):33-43. doi: 10.1159/000337132. Epub 2012 Jul 13. Review.

PMID:
22797275
[PubMed - indexed for MEDLINE]
8.

Dopamine-dependent architecture of cortico-subcortical network connectivity.

Cole DM, Oei NY, Soeter RP, Both S, van Gerven JM, Rombouts SA, Beckmann CF.

Cereb Cortex. 2013 Jul;23(7):1509-16. doi: 10.1093/cercor/bhs136. Epub 2012 May 29.

PMID:
22645252
[PubMed - indexed for MEDLINE]
9.

Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia.

Dowd EC, Barch DM.

PLoS One. 2012;7(5):e35622. doi: 10.1371/journal.pone.0035622. Epub 2012 May 4.

PMID:
22574121
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.

Kim JH, Son YD, Kim HK, Lee SY, Cho SE, Kim YB, Cho ZH.

J Clin Psychopharmacol. 2011 Aug;31(4):507-11. doi: 10.1097/JCP.0b013e318222353a.

PMID:
21694619
[PubMed - indexed for MEDLINE]
11.

Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues.

Bédard AM, Maheux J, Lévesque D, Samaha AN.

Neuropsychopharmacology. 2011 May;36(6):1248-59. doi: 10.1038/npp.2011.10. Epub 2011 Feb 16.

PMID:
21326191
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.

Zhornitsky S, Potvin S, Stip E, Rompré PP.

Eur Neuropsychopharmacol. 2010 Oct;20(10):695-703. doi: 10.1016/j.euroneuro.2010.04.011. Epub 2010 Jun 3.

PMID:
20605419
[PubMed - indexed for MEDLINE]
13.

Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence.

Vergne DE, Anton RF.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):50-4. Review.

PMID:
20201815
[PubMed - indexed for MEDLINE]
14.

Quetiapine blocks cocaine-induced enhancement of brain stimulation reward.

Gallo A, Lapointe S, Stip E, Potvin S, Rompré PP.

Behav Brain Res. 2010 Mar 17;208(1):163-8. doi: 10.1016/j.bbr.2009.11.029. Epub 2009 Nov 24.

PMID:
19941909
[PubMed - indexed for MEDLINE]
15.

Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Walter H, Kammerer H, Frasch K, Spitzer M, Abler B.

Psychopharmacology (Berl). 2009 Sep;206(1):121-32. doi: 10.1007/s00213-009-1586-4. Epub 2009 Jun 12.

PMID:
19521678
[PubMed - indexed for MEDLINE]
16.

From real-world events to psychosis: the emerging neuropharmacology of delusions.

Morrison PD, Murray RM.

Schizophr Bull. 2009 Jul;35(4):668-74. doi: 10.1093/schbul/sbp049. Epub 2009 Jun 1.

PMID:
19487337
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Dopamine and reward: the anhedonia hypothesis 30 years on.

Wise RA.

Neurotox Res. 2008 Oct;14(2-3):169-83. doi: 10.1007/BF03033808. Review.

PMID:
19073424
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Schizophrenia: a computational reinforcement learning perspective.

Frank MJ.

Schizophr Bull. 2008 Nov;34(6):1008-11. doi: 10.1093/schbul/sbn123. Epub 2008 Sep 12. No abstract available.

PMID:
18791075
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2008 Mar;196(4):673-84. Epub 2007 Dec 21.

PMID:
18097655
[PubMed - indexed for MEDLINE]
20.

The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.

Kirsch P, Ronshausen S, Mier D, Gallhofer B.

Pharmacopsychiatry. 2007 Sep;40(5):196-8.

PMID:
17874350
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk